Review article · 3 May 2019
EditorialPublished 2015
Solid Lipid Nanoparticle: An Overview
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Suryakanta Swain and Sitty Manohar Babu PDF Share this article
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 30 Dec 2025
Solid Lipid Nanoparticles, Oral Drug Delivery, and Stability
Editorial · 12 Dec 2025
Solid Lipid Nanoparticles to Improve Oral Bioavailability of Poorly Soluble Anticancer Agents
Opinion · 16 Dec 2024
Solid Lipid Nanoparticles (SLNs): Enhancing Bioavailability and Stability in Pharmaceutical Applications
Article · 24 Jul 2024
Investigating novel methods for formulating solid lipid nanoparticles
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Suryakanta Swain”
- BylineArticles whose byline prints “Sitty Manohar Babu”

